Basket cover image
17 handpicked stocks

Company Toolbox

Invest in the businesses that power other businesses. These carefully selected companies provide the essential tools, platforms, and services that enterprises can't live without. With recurring revenue models and high customer retention, they form the backbone of our digital economy.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+7

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juin 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

MSFT

Microsoft Corporation

MSFT

Current price

$509.77

Provides the essential Azure cloud infrastructure and Office 365 productivity suite used by businesses globally.

ADBE

Adobe Systems Inc.

ADBE

Current price

$361.03

Offers the indispensable Creative Cloud and Experience Cloud suites for digital content creation and marketing.

CRM

Salesforce Inc

CRM

Current price

$246.00

Dominates the customer relationship management market with its essential platform for sales, service, and marketing.

About This Group of Stocks

1

Our Expert Thinking

This collection focuses on the B2B companies providing mission-critical services to other businesses. These firms benefit from high customer retention and recurring revenue, creating stability even in uncertain markets. By powering the engine room of commerce, they're positioned for durable growth as digital transformation accelerates.

2

What You Need to Know

These companies typically feature strong cash flows, defensible market positions, and growth tied to overall business activity rather than consumer trends. Many operate as "picks and shovels" businesses, providing essential infrastructure regardless of which specific companies win in their industries.

3

Why These Stocks

We've selected market leaders in non-discretionary corporate spending categories - from cloud computing and enterprise software to payment networks and logistics services. These companies have established platforms, wide client bases, and provide services that businesses simply cannot function without in today's digital economy.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+32.13%

Group Performance Snapshot

32.13%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 32.13% over the next year.

15 of 16

Stocks Rated Buy by Analysts

15 of 16 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🔄

Recurring Revenue Machines

These companies have mastered the subscription economy, with steady, predictable income streams that investors love. Their services are so embedded in client operations that switching costs are extremely high.

🚀

Riding The Digital Wave

As businesses everywhere rush to digitize operations, these companies are selling the essential tools making it all possible. The digital transformation trend is still in early innings with years of growth ahead.

🛡️

Business-Essential Services

These aren't nice-to-have tools - they're mission-critical services companies can't operate without. This creates remarkable stability and defensibility even when budgets get tight or markets turn uncertain.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Orphan Drug Moats: Leaders In Rare Disease

Orphan Drug Moats: Leaders In Rare Disease

The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.

View stocks
Nvidia's China Chip Pivot

Nvidia's China Chip Pivot

Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.

View stocks
Navigating The Autonomous Driving Shakeout

Navigating The Autonomous Driving Shakeout

A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.